Td Asset Management Inc Enanta Pharmaceuticals Inc Transaction History

Td Asset Management Inc

$106 Billion
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$48.29 - $71.27 $24,145 - $35,635	500 Added 4.9%	10,700 $561,000
Q2 2022 Aug 04, 2022	SELL	$38.13 - $76.93 $118,203 - $238,483	-3,100 Reduced 23.31%	10,200 $482,000
Q1 2022 May 10, 2022	SELL	$56.06 - $74.11 $683,932 - $904,142	-12,200 Reduced 47.84%	13,300 $947,000
Q4 2021 Feb 10, 2022	BUY	$60.19 - $97.37 $391,235 - $632,905	6,500 Added 34.21%	25,500 $1.91 Million
Q3 2021 Nov 09, 2021	BUY	$41.02 - $58.65 $779,380 - $1.11 Million	19,000 New	19,000 $1.08 Million
Q2 2021 Aug 11, 2021	SELL	$43.76 - $53.11 $780,984 - $947,854	-17,847 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$41.69 - $54.95 $220,957 - $291,235	-5,300 Reduced 22.9%	17,847 $880,000
Q3 2020 Nov 10, 2020	SELL	$43.36 - $53.53 $264,496 - $326,533	-6,100 Reduced 20.86%	23,147 $1.06 Million
Q2 2020 Aug 13, 2020	BUY	$46.37 - $57.58 $37,096 - $46,064	800 Added 2.81%	29,247 $1.47 Million
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $185,012 - $285,200	-4,600 Reduced 13.92%	28,447 $1.46 Million
Q4 2019 Feb 11, 2020	SELL	$57.95 - $66.61 $191,235 - $219,813	-3,300 Reduced 9.08%	33,047 $2.04 Million
Q3 2019 Nov 07, 2019	SELL	$60.08 - $88.17 $132,236 - $194,062	-2,201 Reduced 5.71%	36,347 $2.18 Million
Q2 2019 Aug 01, 2019	BUY	$81.3 - $97.35 $276,420 - $330,990	3,400 Added 9.67%	38,548 $3.25 Million
Q1 2019 May 08, 2019	BUY	$69.08 - $105.66 $230,105 - $351,953	3,331 Added 10.47%	35,148 $3.36 Million
Q4 2018 Feb 01, 2019	BUY	$65.41 - $84.65 $9,484 - $12,274	145 Added 0.46%	31,817 $2.25 Million
Q3 2018 Nov 01, 2018	SELL	$85.46 - $126.37 $776,745 - $1.15 Million	-9,089 Reduced 22.3%	31,672 $2.71 Million
Q2 2018 Jul 31, 2018	BUY	$81.85 - $120.51 $2.24 Million - $3.29 Million	27,319 Added 203.24%	40,761 $4.72 Million
Q1 2018 May 11, 2018	BUY	$57.91 - $92.15 $17,836 - $28,382	308 Added 2.35%	13,442 $1.09 Million
Q4 2017 Feb 02, 2018	BUY	$45.65 - $59.37 $599,567 - $779,765	13,134	13,134 $771,000

Others Institutions Holding ENTA

# of Institutions

107

Shares Held

18.3M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$15.1 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$14.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$13.2 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$10.7 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.22M
Shares

$8.72 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $148M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account